Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.51 USD | -3.32% | -1.26% | -45.87% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.87% | 652M | |
+32.36% | 694B | |
+29.95% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.45% | 239B | |
-3.35% | 209B | |
+10.05% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- JPMorgan Starts EyePoint Pharmaceuticals With Overweight Rating, $35 Price Target